Multiple Sclerosis and Related Disorders This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

The effectiveness of natalizumab vs fingolimod – a comparison of international registry studies
Publication date: Available online 8 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Johanna B Andersen, Sifat Sharmin, Mathilde Lefort, Nils Koch-Henriksen, Finn Sellebjerg, Per Soelberg Sørensen, Claudia C Pfleger, Peter V Rasmussen, Michael B Jensen, Jette L Frederiksen, Stephan Bramow, Henrik K Mathiesen, Karen I Schreiber, Dana Horakova, Eva K Havrdova, Raed Alroughani, Guillermo Izquierdo, Sara Eichau, Serkan Ozakbas, Francesco Patti (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 8, 2021 Category: Neurology Source Type: research

A Mindfulness Group Intervention in Newly Diagnosed Persons with Multiple Sclerosis: A Pilot Study
Publication date: Available online 8 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Sarah A. Morrow, Patricia Riccio, Nancy Vording, Heather Rosehart, Courtney Casserly, Arlene MacDougall (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 8, 2021 Category: Neurology Source Type: research

Cytotoxic profile of CD3+CD20+ T cells in Progressive Multiple Sclerosis – Correspondence
Publication date: Available online 7 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Vinícius O. Boldrini, Raphael P.S. Quintiliano, Lucas Scárdua, Alfredo Damasceno, Leonilda M.B. Santos, Alessandro S. Farias (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 7, 2021 Category: Neurology Source Type: research

Association of Epstein-Barr virus latently expressed genes with multiple sclerosis
Publication date: Available online 7 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Despina Varvatsi, Jan Richter, Christina Tryfonos, Marios Pantzaris, Christina Christodoulou (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 7, 2021 Category: Neurology Source Type: research

Improvement over previous decades in time of diagnosis but not in time of initiating DMD in MS patients in Argentina
Publication date: Available online 7 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Juan I. Rojas, Liliana Patrucco, Agustín Pappolla, Edgardo Cristiano (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 7, 2021 Category: Neurology Source Type: research

Attenuation of antibody response to SARS-CoV-2 infection in patients with multiple sclerosis on ocrelizumab: a case-control study
Publication date: Available online 7 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): William L. Conte (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 7, 2021 Category: Neurology Source Type: research

Conus involvement and leptomeningeal enhancement in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder: A case report
Publication date: Available online 7 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Amy Li Safadi, Cory J Myers, Nancy N. Hu, Benjamin Osborne (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 7, 2021 Category: Neurology Source Type: research

Novel de novo TREX1 mutation in a patient with retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations mimicking demyelinating disease
Publication date: Available online 7 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Gabrielle Macaron, Jean Khoury, Rula A. Hajj-Ali, Richard A. Prayson, Sunil Srivastava, Justis P. Ehlers, Hafsa Mamsa, M. Kathryn Liszewski, Joanna C. Jen, Robert A. Bermel, Daniel Ontaneda (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 7, 2021 Category: Neurology Source Type: research

COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies
Publication date: Available online 5 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Afagh Garjani, Rodden M Middleton, Rachael Hunter, Katherine A Tuite-Dalton, Alasdair Coles, Ruth Dobson, Martin Duddy, Stella Hughes, Owen R Pearson, David Rog, Emma C Tallantyre, Roshan das Nair, Richard Nicholas, Nikos Evangelou (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 6, 2021 Category: Neurology Source Type: research

A Pilot Trial of Autologous Hematopoietic Stem Cell Transplant in Neuromyelitis Optic Spectrum Disorder
Publication date: Available online 4 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Jodie M. Burton, Peter Duggan, Fiona Costello, Luanne Metz, Jan Storek (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 5, 2021 Category: Neurology Source Type: research

Prediction of unenhanced lesions evolution in multiple sclerosis using radiomics-based models: A Machine Learning Approach
Publication date: Available online 4 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Yuling Peng, Yineng Zheng, Zeyun Tan, Junhang Liu, Yayun Xiang, Huan Liu, Linquan Dai, Yanjun Xie, Jingjie Wang, Chun Zeng, Yongmei Li Prof (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 5, 2021 Category: Neurology Source Type: research

COVID-19 vaccines in multiple sclerosis treated with cladribine or ocrelizumab
Publication date: Available online 4 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Fabio Buttari, Antonio Bruno, Ettore Dolcetti, Federica Azzolini, Paolo Bellantonio, Diego Centonze, Roberta Fantozzi (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 4, 2021 Category: Neurology Source Type: research

Immune Reconstitution Therapy in NMOSD
Publication date: Available online 4 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Staley A. Brod (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 4, 2021 Category: Neurology Source Type: research

Natalizumab differentially affects plasmablasts and B cells in multiple sclerosis
Publication date: Available online 1 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): Alexander Cuculiza Henriksen, Cecilie Ammitzbøll, Eva Rosa Petersen, Oskar McWilliam, Finn Sellebjerg, Marina Rode von Essen, Jeppe Romme Christensen (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 1, 2021 Category: Neurology Source Type: research

Anti-CD20 antibody therapy and risk of infection in patients with demyelinating diseases
Publication date: Available online 1 May 2021Source: Multiple Sclerosis and Related DisordersAuthor(s): N.R. Oksbjerg, S.D. Nielsen, M. Blinkenberg, M. Magyari, F. Sellebjerg (Source: Multiple Sclerosis and Related Disorders)
Source: Multiple Sclerosis and Related Disorders - May 1, 2021 Category: Neurology Source Type: research